openPR Logo
Press release

"Cybersecurity, Healthcare Innovators PTPI, SWISF, OCEA, DGLY, LYT, SIGL, Amid FBI Warnings, Signal App Breach, and Data Privacy Crisis"

03-27-2025 01:10 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

"Cybersecurity, Healthcare Innovators PTPI, SWISF, OCEA,

With cybersecurity risks reaching unprecedented levels-amplified by the recent Signal app breach impacting White House officials and large-scale cyberattacks on X (formerly Twitter)-government agencies and private enterprises are issuing urgent warnings. The FBI has raised red flags about vulnerabilities within the digital infrastructure that powers our financial systems, healthcare networks, and personal communications. Additionally, The fusion of cybersecurity vulnerabilities and healthcare data breaches is putting patient records, financial data, and personal identities in the crosshairs. According to the Department of Health and Human Services (HHS), over 100 million healthcare records were compromised in 2024. This alarming trend has accelerated demand for innovative, compliant, and secure tech solutions across both industries.

Amid this wave of digital insecurity, several public companies are stepping forward with breakthrough innovations aimed at safeguarding the most critical aspects of modern life: our money, our health, and our identities.

Petros Pharmaceuticals, Inc. (Nasdaq: PTPI): AI-Powered Credentialing for Digital Health Access is addressing healthcare cybersecurity head-on with its Software-as-a-Medical Device (SaMD) innovation. A new partnership with a Big Data analytics firm brings AI-enhanced identity verification and credentialing to its over-the-counter pharmaceutical access programs. As the self-care and telehealth markets surge, Petros is ensuring HIPAA-aligned safety for digital-first consumers.

Digital Ally, Inc. (Nasdaq: DGLY): Patented Safety for Law Enforcement and Fleets is strengthening its reputation as a leader in video security, receiving six new patents over the past year. The company's technology spans body-worn cameras, fleet safety systems, and breathalyzers, delivering data integrity and accountability in high-stakes environments such as law enforcement and emergency services.

Sekur Private Data Ltd. (OTCQB: SWISF) (CSE: SKUR): Swiss-Based Fortress for Enterprise Communications is rolling out its Sekur Corporate Suite, a robust, Swiss-hosted solution offering end-to-end encrypted messaging, email, and file sharing. With no reliance on Big Tech infrastructure and full compliance with Swiss privacy laws, Sekur provides unmatched data sovereignty for enterprises and high-net-worth individuals worldwide-at a time when corporate and healthcare systems are under constant digital assault.

Lytus Technologies (NASDAQ: LYT) Reports 24% Revenue Growth for H1 FY2025 is a leader in platform services and next-generation technology, announced a strong financial performance for the six months ending September 30, 2024. The company reported $12.01 million in revenue, marking a 24% year-over-year increase from $9.66 million. Lytus also achieved a net profit of $648,972, a sharp turnaround from a net loss of $1.28 million in the same period last year-driven by efficient cost management and a profit margin of 5.4%.

Lytus Technologies (NASDAQ: LYT) Reports 24% Revenue Growth for H1 FY2025 is a leader in platform services and next-generation technology, announced a strong financial performance for the six months ending September 30, 2024. The company reported $12.01 million in revenue, marking a 24% year-over-year increase from $9.66 million. Lytus also achieved a net profit of $648,972, a sharp turnaround from a net loss of $1.28 million in the same period last year-driven by efficient cost management and a profit margin of 5.4%.

Signal Advance, Inc. (OTC: SIGL): Redefining Encryption with Analog Guard Registered In a cybersecurity landscape dominated by digital encryption, Signal Advance is making waves with its patented Analog Guard Registered technology. By utilizing real-time signal transformation, the company offers a highly secure alternative to traditional methods. This innovation is particularly relevant for financial transactions, healthcare systems, and military communications, where standard digital defenses often fall short.

Ocean Biomedical, Inc. (Nasdaq: OCEA): Resetting Cancer Treatment with Immunotherapy Breakthroughs has published landmark research showing that its proprietary cancer immunotherapy candidates work synergistically with TKIs (like osimertinib) to treat EGFR-mutant non-small cell lung cancer (NSCLC). More significantly, the company's approach restores treatment sensitivity in resistant tumors-offering a potential paradigm shift in cancer therapy that extends hope for patients where current treatments no longer work

Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), Sekur Private Data Ltd. (OTCQB: SWISF) (CSE: SKUR), Lytus Technologies (NASDAQ: LYT), Signal Advance, Inc. (OTC: SIGL), Digital Ally, Inc. (Nasdaq: DGLY) and Ocean Biomedical, Inc. (Nasdaq: OCEA) stand out as trailblazers addressing these dual concerns-improving medical outcomes while defending against digital intrusions. Their technologies reflect the urgency to modernize both care delivery and data protection. Making them companies to watch in 2025.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cybersecurity-healthcare-innovators-ptpi-swisf-ocea-dgly-lyt-sigl-amid-fbi-warnings-signal-app-breach-and-data-privacy-crisis]
Country: United States
Website: http://www.thestreetreports.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release "Cybersecurity, Healthcare Innovators PTPI, SWISF, OCEA, DGLY, LYT, SIGL, Amid FBI Warnings, Signal App Breach, and Data Privacy Crisis" here

News-ID: 3940358 • Views:

More Releases from ABNewswire

Rheumatoid Arthritis Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | AbbVie, Pfizer, Regeneron/Sanofi, Eli Lilly and Company, UCB BIOSCIENCES GmbH
Rheumatoid Arthritis Market to Experience Notable Growth in Forecast Span by 203 …
The Key Rheumatoid Arthritis Companies in the market include - Eli Lilly and Company/Incyte Corporation, AbbVie, Cyxone, IGM Biosciences, Regeneron/Sanofi, UCB BIOSCIENCES GmbH, AbbVie, Pfizer, Changchun GeneScience Pharma, Novartis, Istituto Giannina Gaslini, and others. The Rheumatoid Arthritis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Rheumatoid Arthritis pipeline products will significantly revolutionize the Rheumatoid Arthritis market dynamics. DelveInsight's "Rheumatoid
Rheumatoid Arthritis Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | AbbVie, Pfizer, Regeneron/Sanofi, Eli Lilly and Company, UCB BIOSCIENCES GmbH
Rheumatoid Arthritis Market to Experience Notable Growth in Forecast Span by 203 …
The Key Rheumatoid Arthritis Companies in the market include - Eli Lilly and Company/Incyte Corporation, AbbVie, Cyxone, IGM Biosciences, Regeneron/Sanofi, UCB BIOSCIENCES GmbH, AbbVie, Pfizer, Changchun GeneScience Pharma, Novartis, Istituto Giannina Gaslini, and others. The Rheumatoid Arthritis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Rheumatoid Arthritis pipeline products will significantly revolutionize the Rheumatoid Arthritis market dynamics. DelveInsight's "Rheumatoid
RS Digital Unveils Next-Generation AI SEO Framework to Help UK Businesses Win in Google's AI Search
RS Digital Unveils Next-Generation AI SEO Framework to Help UK Businesses Win in …
RS Digital, a pioneering digital marketing agency led by founder Gareth Owen, today announced the next phase of its AI SEO services, designed to help UK businesses secure a competitive advantage in Google's rapidly evolving AI-powered search results. Colne, Lancashire - October 2, 2025 - Since its official launch in July 2025, RS Digital's AI SEO division has focused on preparing clients for the biggest change to Google in a decade
Big Kid Circus Unveils Ambitious Plans for New Home at Former Oil Village, East Calder
Big Kid Circus Unveils Ambitious Plans for New Home at Former Oil Village, East …
Big Kid Circus is excited to announce proposals for a new base at the former Oil Village site in East Calder. The vision is for a vibrant, sustainable facility that will serve as a multi-functional training school, provide community amenities, and enhance access to green space. East Calder, West Lothian - 2nd October, 2025 - Located at Oakbank, the current under-utilised site offers a unique opportunity to bring together performance, education

All 5 Releases


More Releases for Nasdaq:

Peraso (NASDAQ: PRSO) Pushes Back on Mobix Labs (NASDAQ: MOBX) Takeover Bid, Val …
Peraso Inc. (NASDAQ: PRSO), a leading innovator in mmWave wireless solutions, has officially acknowledged receipt of an unsolicited, non-binding acquisition proposal from Mobix Labs, Inc. (NASDAQ: MOBX). The offer proposes a stock-for-stock exchange that values Peraso at approximately $1.20 per share, representing a 20% premium over its 30-day average closing price. However, Peraso is contesting several key points made in Mobix's June 26 press release. Financials Mischaracterized, Says Peraso Peraso rebuffed Mobix's
ZenaTech's (Nasdaq: ZENA) Nasdaq Listing: A Launchpad for Growth and Innovation
On October 1, ZenaTech (Nasdaq: ZENA) made its debut on the Nasdaq, a pivotal milestone for the company specializing in AI-driven drone solutions and enterprise SaaS (software-as-a-service) applications. As businesses increasingly seek innovative ways to streamline operations and boost productivity, ZenaTech stands ready to meet these demands with its advanced AI drone solutions and comprehensive software applications. Under the leadership of CEO Dr. Shaun Passley, ZenaTech aims to leverage its
Investors Alert: EMCORE (NASDAQ: EMKR), AGBA Group (NASDAQ: AGBA), Peraso Inc. ( …
EMCORE Corporation (NASDAQ: EMKR) saw its shares soar today following a major announcement from Mobix Labs (NASDAQ: MOBX). Mobix Labs, a leader in advanced wireless solutions for military and defense, has submitted a proposal to acquire all outstanding shares of EMCORE for $3.80 per share in cash, positioning itself as a key player in the aerospace and defense sectors. This move could provide immediate value to shareholders, making it an
Market Movers to Watch: Black Diamond (Nasdaq: BDTX), Peraso Inc. (NASDAQ: PRSO) …
Pre-market trading is heating up as Black Diamond Therapeutics, Inc. (Nasdaq: BDTX) surges on positive Phase 2 data for its cancer treatment BDTX-1535. Peraso Inc. (NASDAQ: PRSO) continues its expansion into the Asian markets and a major military contract. Kaival Brands (NASDAQ: KAVL) saw its stock surge in early trading today on merger announcement. Other stocks to watch include Banzai International Inc. (NASDAQ: BNZI), which saw a 97.51% rally after
Lawsuit filed for Investors who lost money with Alphabet Inc. (NASDAQ: GOOG, NAS …
An investor, who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), filed a lawsuit over alleged violations of Federal Securities Laws by Alphabet Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), have certain options and for certain investors are short and strict deadlines running. Deadline: May 15, 2023. NASDAQ: GOOG, NASDAQ: GOOGL investors should contact the Shareholders
Investigation announced for Investors in NASDAQ: MTTR over possible Wrongdoing a …
An investigation was announced for investors in shares of Matterport, Inc. (NASDAQ: MTTR) was announced over potential breaches of fiduciary duties by certain officers and directors at Matterport, Inc. Investors who purchased shares of Matterport, Inc. (NASDAQ: MTTR) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Matterport, Inc. directors breached their fiduciary duties and